Task: Answer Verification
Input (English): Question: Does tERT promoter mutation predict radioiodine refractory in distant metastatic differentiated thyroid cancer?
Answer: TERT promoter mutation closely associates with non-RAI-avidity in DM-DTC, and when comparing with BRAF mutation, TERT mutation manifested a worse negative influence on RAI uptake. It could also be used as a predictive marker to early identify refractory to RAI.
Output (English): yes